Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 273489, 8 pages
http://dx.doi.org/10.1155/2015/273489
Research Article

Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials

1III. Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
2Chirurgische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
3Klinik für Strahlentherapie und Radioonkologie, Universitätsmedizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
4Pathologisches Institut, Universitätsmedizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
5Interdisziplinäres Tumorzentrum, Universitätsmedizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany

Received 15 December 2014; Accepted 3 March 2015

Academic Editor: Eiji Sakai

Copyright © 2015 M. Kripp et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • Ralf-Dieter Hofheinz, Melanie Kripp, and Sylvie Lorenzen, “Combination of cetuximab with radio-chemotherapy in patients with esophageal cancer: less is more!,” Journal Of Thoracic Disease, vol. 7, no. 12, pp. E629–E632, 2015. View at Publisher · View at Google Scholar
  • D. Antoni, S. Bockel, E. Deutsch, and F. Mornex, “Radiothérapie et thérapies ciblées/immunothérapie,” Cancer/Radiothérapie, 2016. View at Publisher · View at Google Scholar
  • Rob Glynne-Jones, and Carlos Carvalho, “Drug Combinations in Preoperative Chemoradiation for Rectal Cancer,” Seminars in Radiation Oncology, vol. 26, no. 3, pp. 211–219, 2016. View at Publisher · View at Google Scholar
  • T.A. Greenhalgh, C. Dearman, and R.A. Sharma, “Combination of Novel Agents with Radiotherapy to Treat Rectal Cancer,” Clinical Oncology, vol. 28, no. 2, pp. 116–139, 2016. View at Publisher · View at Google Scholar
  • Iris Eke, Adeola Y. Makinde, Molykutty J. Aryankalayil, Mansoor M. Ahmed, and C. Norman Coleman, “Comprehensive molecular tumor profiling in Radiation Oncology: How it could be used for precision medicine,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Hélène Poels, Pieter-Jan Cuyle, and Eric Van Cutsem, “Should Biological Targeted Agents be Combined with Preoperative Chemoradiation in Rectal Cancer? An Update,” Multidisciplinary Management of Rectal Cancer, pp. 273–285, 2017. View at Publisher · View at Google Scholar
  • Philippe Rouanet, Eric Rullier, Bernard Lelong, Philippe Maingon, Jean-Jacques Tuech, Denis Pezet, Florence Castan, and St?phanie Nougaret, “Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy,” Diseases of the Colon & Rectum, vol. 60, no. 7, pp. 653–663, 2017. View at Publisher · View at Google Scholar
  • Ben Creavin, and Desmond Winter, “Rectal Cancer That Responds to Radiotherapy,” Coloproctology, pp. 209–239, 2017. View at Publisher · View at Google Scholar
  • Jason Paik, Cindy Kin, and George A. Fisher, “Future Therapies in Medical Oncology,” Surgical Techniques in Rectal Cancer, pp. 111–124, 2017. View at Publisher · View at Google Scholar
  • Bin Ma, Qingzhou Xu, Yongxi Song, Peng Gao, and Zhenning Wang, “Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer,” Future Oncology, 2017. View at Publisher · View at Google Scholar
  • Benson, Howard S. Hochster, Sarah Hoffe, Steven Hunt, Ahmed Kamel, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey Meyerhardt, Mary F. Mulcahy, Steven Nurkin, Leonard Saltz, Sunil Sharma, Constantinos T. Sofocleous, Elena M. Stoffel, Christopher G. Willett, Evan Wuthrick, Yi-Jen Chen, Kristen K. Ciombor, Harry S. Cooper, Dustin Deming, Paul F. Engstrom, Jean L. Grem, Axel Grothey, Natalie Kirilcuk, Alan P. Venook, James D. Murphy, David Shibata, John M. Skibber, Mahmoud M. Al-Hawary, Eden Stotsky-Himelfarb, Deborah A. Freedman-Cass, Kristina M. Gregory, Lisa Gurski, Lynette Cederquist, and Stacey Cohen, “Rectal cancer, version 2.2018 clinical practice guidelines in Oncology,” JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 7, pp. 874–901, 2018. View at Publisher · View at Google Scholar
  • Maria Antonietta Gambacorta, Antonino De Paoli, Marco Lupattelli, Giuditta Chiloiro, Angela Pia Solazzo, Brunella Barbaro, Sergio Alfieri, Fabio Maria Vecchio, Jacopo Lenkowicz, Francesco Navarria, Elisa Palazzari, Bertola Giulio, Alessandro Frattegiani, Bruce Minsky, and Vincenzo Valentini, “Phase I and II trial on infusional 5-Fluorouracil and Gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up,” Clinical and Translational Radiation Oncology, 2018. View at Publisher · View at Google Scholar